Concerto Biosciences
Phase 1We measure, map, and harness the microbial world to create best-in-class products.
Market Cap
Private
Pipeline
1
drug candidates
Patents
—
Publications
—
Private Company
Total funding raised: $22.5M
About
We measure, map, and harness the microbial world to create best-in-class products.
Microbiome
Pipeline
11 drug in pipeline
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| ENS-002 | Atopic Dermatitis | Phase 1 |
Funding History
2Total raised:$22.5M
Series A$18MMay 15, 2023
Seed$4.5MOct 15, 2021